Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups
Article first published online: 13 MAR 2013
© 2013 International Society on Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis
Volume 11, Issue 3, pages 444–451, March 2013
How to Cite
PINEO, G. F., GALLUS, A. S., RASKOB, G. E., CHEN, D., RAMIREZ, L.-M., RAMACCIOTTI, E., LASSEN, M. R. and WANG, L. (2013), Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups. Journal of Thrombosis and Haemostasis, 11: 444–451. doi: 10.1111/jth.12109
- Issue published online: 13 MAR 2013
- Article first published online: 13 MAR 2013
- Accepted manuscript online: 19 DEC 2012 11:16PM EST
- Received 17 August 2012, accepted 6 December 2012
Table S1. All venous thromboembolism by subgroups.
|jth12109_sm_Appendix.docx||33K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.